View in EDS PDF Full Text

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Authors: Jamookeeah, Clare1, Robinson, Paul1, O'Reilly, Karl1 KO'Reilly@otsuka-europe.com, Lundberg, Johan2, Gisby, Martin1, Ländin, Michael2, Skov, Jakob3, Trueman, David4
Source: BMC Endocrine Disorders. 5/16/2016, Vol. 16, p1-9. 9p.
Database: Academic Search Ultimate
Description
ISSN:14726823
DOI:10.1186/s12902-016-0104-z